BBT Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,004
Closed -$273K 232
2018
Q4
$273K Buy
+3,004
New +$281K 0.25% 203
2016
Q1
Sell
-243,505
Closed -$18.7M 99
2015
Q4
$18.7M Hold
243,505
2.22% 13
2015
Q3
$16.3M Hold
243,505
1.52% 15
2015
Q2
$18M Buy
+243,505
New +$18.6M 1.65% 15
2015
Q1
Sell
-29,171
Closed -$2.11M 191
2014
Q4
$2.11M Sell
29,171
-75,742
-72% -$5.26M 0.18% 111
2014
Q3
$6.5M Buy
104,913
+74,715
+247% +$4.75M 0.36% 78
2014
Q2
$1.93M Buy
+30,198
New +$1.83M 0.12% 166

Other funds holding MDT

BBT Capital Management's MDT Position: Q1 2019 in Review

BBT Capital Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 3,004 shares — an estimated $273K sold.

BBT Capital Management first reported a position in MDT in Q2 2014 and held it in 7 quarters. The position peaked at $18.7M in Q4 2015. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • BBT Capital Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • BBT Capital Management sold 3,004 Medtronic shares in Q1 2019, an estimated $273K.
  • BBT Capital Management first reported a position in Medtronic in Q2 2014 and held it in 7 quarters.
  • BBT Capital Management's Medtronic position peaked at $18.7M in Q4 2015.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on BBT Capital Management's 13F filing for Q1 2019, filed 10 May 2019.